Related Experiment Video
Updated: Apr 14, 2026

09:56
CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans
Published on: November 14, 2018
12.9K
Marker-Free CRISPR/Cas9 RNP Transformation for Gene Disruption in Aspergillus fumigatus
Clara Valero1, Jamie Tindale1, Michael J Bromley2
1Manchester Fungal Infection Group, University of Manchester, Manchester, UK.
Methods in Molecular Biology (Clifton, N.J.)
|April 12, 2026
Summary
We describe a CRISPR-Cas9 protocol for marker-free genetic engineering in filamentous fungi. This method enhances efficiency and is adaptable for various strains and species, including Aspergillus fumigatus.
Area of Science:
- Molecular Biology
- Mycology
- Genetic Engineering
Background:
- Filamentous fungal pathogens pose significant human health risks.
- CRISPR-based technologies offer advanced genetic engineering capabilities.
- Aspergillus fumigatus is a prevalent human fungal pathogen requiring improved study methods.
Purpose of the Study:
- To present a novel protocol for CRISPR-Cas9 mediated genetic engineering.
- To enable selection marker-free transformation in filamentous fungi.
- To facilitate adaptable genetic manipulation across fungal species.
Main Methods:
- Utilized CRISPR-Cas9 system for targeted gene editing.
- Developed a selection marker-free transformation protocol.
- Optimized the protocol for filamentous fungi, including Aspergillus fumigatus.
Main Results:
- Successfully achieved marker-free CRISPR-Cas9 transformation in filamentous fungi.
- Demonstrated the protocol's adaptability to multiple strains and species.
- Established a more efficient genetic engineering method for fungal pathogens.
Conclusions:
- The described protocol significantly advances genetic engineering in filamentous fungi.
- This method provides a versatile tool for studying fungal pathogens like Aspergillus fumigatus.
- Selection marker-free CRISPR-Cas9 transformation broadens the scope of fungal genetic research.

